Short Interest in NanoVibronix, Inc. (NASDAQ:NAOV) Drops By 94.2%

NanoVibronix, Inc. (NASDAQ:NAOV) was the recipient of a large decrease in short interest in February. As of February 15th, there was short interest totalling 95,700 shares, a decrease of 94.2% from the January 31st total of 1,660,000 shares. Approximately 1.1% of the shares of the company are short sold. Based on an average trading volume of 3,450,000 shares, the short-interest ratio is currently 0.0 days.

NanoVibronix Price Performance

Shares of NAOV traded up $0.02 on Thursday, reaching $0.35. 145,369 shares of the stock traded hands, compared to its average volume of 5,514,046. The stock’s 50-day moving average price is $0.49 and its 200-day moving average price is $0.58. The firm has a market cap of $3.05 million, a price-to-earnings ratio of -0.28 and a beta of 1.63. NanoVibronix has a 12 month low of $0.31 and a 12 month high of $1.27.

About NanoVibronix

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.